Jon Kessler - Mar 22, 2024 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Jon Kessler
Stock symbol
HQY
Transactions as of
Mar 22, 2024
Transactions value $
-$1,854,731
Form type
4
Date filed
3/26/2024, 10:13 AM
Previous filing
Sep 29, 2023
Next filing
Mar 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Options Exercise $840K +60K +60% $14.00 160K Mar 22, 2024 by GKF, LLC F1
transaction HQY Common Stock Sale -$2.69M -33.8K -21.05% $79.81 127K Mar 22, 2024 by GKF, LLC F2
holding HQY Common Stock 214K Mar 22, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HQY Stock Option (right to buy) Options Exercise $0 -60K -100% $0.00* 0 Mar 22, 2024 Common Stock 60K $14.00 by GKF, LLC F3
holding HQY Stock Option (right to buy) 34.8K Mar 22, 2024 Common Stock 34.8K $41.28 by GKF, LLC F3
holding HQY Stock Option (right to buy) 23.9K Mar 22, 2024 Common Stock 23.9K $61.72 by GKF, LLC F3
holding HQY Stock Option (right to buy) 12.8K Mar 22, 2024 Common Stock 12.8K $73.61 by GKF, LLC F3
holding HQY Stock Option (right to buy) 17.4K Mar 22, 2024 Common Stock 17.4K $41.28 Direct F3
holding HQY Stock Option (right to buy) 23.9K Mar 22, 2024 Common Stock 23.9K $61.72 Direct F3
holding HQY Stock Option (right to buy) 38.3K Mar 22, 2024 Common Stock 38.3K $73.61 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the GKF, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.53 to $80.46 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
F3 The option is immediately exercisable.